Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
MRK [NYSE]
Merck & Co. Inc.
IndexDJIA S&P500 P/E31.47 EPS (ttm)1.90 Insider Own0.03% Shs Outstand2.88B Perf Week0.10%
Market Cap172.47B Forward P/E16.69 EPS next Y3.58 Insider Trans2.37% Shs Float2.87B Perf Month5.26%
Income5.61B PEG7.82 EPS next Q0.88 Inst Own75.70% Short Float0.97% Perf Quarter4.02%
Sales43.55B P/S3.96 EPS this Y-26.50% Inst Trans-1.21% Short Ratio3.44 Perf Half Y6.41%
Book/sh16.58 P/B3.61 EPS next Y2.69% ROA5.40% Target Price61.83 Perf Year30.72%
Cash/sh4.64 P/C12.88 EPS next 5Y4.03% ROE11.50% 52W Range43.54 - 60.58 Perf YTD21.30%
Dividend1.76 P/FCF33.09 EPS past 5Y-16.50% ROI6.60% 52W High-1.30% Beta0.40
Dividend %2.94% Quick Ratio1.50 Sales past 5Y13.00% Gross Margin59.80% 52W Low37.31% ATR0.73
Employees77300 Current Ratio1.90 Sales Q/Q-0.70% Oper. Margin17.90% RSI (14)59.12 Volatility0.88% 1.23%
OptionableYes Debt/Eq0.48 EPS Q/Q126.70% Profit Margin12.90% Rel Volume0.75 Prev Close60.11
ShortableYes LT Debt/Eq0.38 EarningsJul 29 BMO Payout90.60% Avg Volume8.08M Price59.79
Recom2.50 SMA202.62% SMA502.67% SMA2009.37% Volume6,053,404 Change-0.53%
30-Apr-14Reiterated Argus Buy $62 → $66
11-Apr-14Reiterated MKM Partners Buy $64 → $70
05-Feb-14Reiterated Argus Buy $54 → $62
14-Jan-14Reiterated MKM Partners Buy $59 → $64
03-Jun-13Reiterated MKM Partners Buy $54 → $59
15-Apr-13Reiterated Barclays Overweight $45 → $60
04-Feb-13Reiterated MKM Partners Buy $51 → $52
04-Feb-13Reiterated Barclays Overweight $46 → $45
20-Nov-12Upgrade MKM Partners Neutral → Buy $47 → $51
17-Oct-12Reiterated MP Advisors Outperform $45 → $50
30-Jul-12Reiterated UBS Buy $45 → $50
13-Jul-12Upgrade MP Advisors Market Perform → Outperform $45
03-Feb-12Reiterated Barclays Capital Overweight $38 → $40
03-Feb-12Downgrade MKM Partners Buy → Neutral $42 → $40
29-Nov-11Initiated MKM Partners Buy $38
14-Sep-11Reiterated Barclays Capital Overweight $41 → $38
16-May-11Reiterated UBS Buy $40 → $42
04-Feb-11Reiterated UBS Buy $42 → $40
24-Jan-11Reiterated Deutsche Bank Buy $48 → $43
24-Jan-11Reiterated Barclays Capital Overweight $43 → $41
02-Sep-14 03:30PM  Regeneron/Sanofi Presents Encouraging Alirocumab Data Zacks
02:34PM  Bad news in Hong Kong is good news for Singapore at CNBC
08:30AM  Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab, the Companys Investigational Anti-PD-1 Antibody, at ESMO 2014 Business Wire
12:34AM  S.Korea lifts ban on beef with feed additive -food ministry Reuters
01-Sep-14 11:00PM  S.Korea lifts ban on beef with feed additive -food ministry Reuters
07:00PM  Identity Crisis in S&P 500 as Range of Valuations Narrows Bloomberg
28-Aug-14 11:20AM  Pharma Claims Free Speech Rights are Being Trampled in Off-Label Case at The Wall Street Journal
27-Aug-14 06:00PM  Pfizer and Merck Collaborate to Develop Lung Cancer Therapy Zacks
01:11PM  [video] Options Insight: Unusual Activities on The Dow at Bloomberg
11:00AM  [video] Merck & Pfizer team up at CNBC
09:21AM  Will This Coverage Initiation Affect Merck (MRK) Stock Today? at TheStreet
09:17AM  UPDATE: Deutsche Bank Initiates Coverage On Merck Benzinga
26-Aug-14 06:45PM  Merck, Pfizer combining drugs Investor's Business Daily
06:24PM  Your first trade for Wednesday at CNBC
05:26PM  Cardiome Pharma Signs Agreement with Eurolab for Brinavess Zacks
04:18PM  Merck Is at the $60 Rubicon; Can It Cross This Time? at The Wall Street Journal
04:01PM  The 4 Stocks That Pushed the DJIA and S&P 500 to New Highs 24/7 Wall St.
03:34PM  [video] Why & what of the stock market at CNBC
03:14PM  Why Merck (MRK) Stock Is Gaining Today at TheStreet
02:24PM  Your first trade for Wednesday at CNBC
01:17PM  Your first trade for Wednesday at CNBC
01:00PM  Dow Today: Merck (MRK) Higher at TheStreet
12:59PM  [video] FMHR Final Trade: RIG, MRK & more at CNBC
12:46PM  Midday movers: Ann, Best Buy Co., Exxon & more at CNBC
12:07PM  Merck, Pfizer Combining Drugs In Lung Cancer Study at Investor's Business Daily
09:07AM  Pfizer to test Xalkori lung cancer drug with Merck immunotherapy Reuters
08:42AM  [$$] Pfizer, Merck Team Up on Cancer Study at The Wall Street Journal
08:00AM  Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen Business Wire
25-Aug-14 04:01PM  The 4 Stocks That Helped Lift the S&P Above 2,000 at 24/7 Wall St.
02:07PM  Business events scheduled for Tuesday AP
12:10PM  [video] Jim Cramer Says Roche's "Bolt-On" Acquisition Means Big Pharma is Thinking Big at TheStreet
12:01AM  Advaxis, Merck to test immune therapies against prostate cancer Reuters
22-Aug-14 09:00AM  Heart Doctor Pay Drops To $558K As Interventions Scrutinized at Forbes
20-Aug-14 01:03PM  3 Drugs Stocks On The Rise at TheStreet
19-Aug-14 06:27PM  This stock may be hazardous to your financial health Talking Numbers
18-Aug-14 03:45PM  Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data Zacks
08:13AM  Washington Post Off Base In Critiquing Pharma Efforts In Ebola at Forbes
15-Aug-14 06:10PM  Biotech Leader Gilead Sciences Scores Sovaldi Win at Investor's Business Daily
05:44PM  Gilead Wins Sovaldi Dispute With Roche, U.K. Nod at Investor's Business Daily
01:04PM  MERCK & CO. INC. Financials EDGAR Online Financials
10:13AM  Digital Transformation Moves Pharma "Beyond the Pill" at Forbes
09:00AM  Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal PR Newswire
08:00AM  Merck KGaA Q2 Earnings Slip Y/Y, 2014 Sales View Confirmed Zacks
01:57AM  Forget Inversions, These 20 Huge, Profitable Companies Already Pay Zero Tax at Forbes
14-Aug-14 04:00PM  Merck's Insomnia Drug Belsomra Approved by the FDA Zacks
02:57PM  [video] Pfizer and Merck Receive Key Regulatory Approvals at TheStreet
02:42PM  US STOCKS-Wall St rises after Putin comments ease Ukraine worries Reuters
10:09AM  US STOCKS-Wall St edges up after Putin comments, Cisco falls Reuters
09:00AM  Award-Winning Actress S. Epatha Merkerson and Merck Challenge African Americans with Type 2 Diabetes to Get to Their Goals PR Newswire
08:25AM  Why Pfizer (PFE) Stock Is Up Today at TheStreet
07:31AM  US STOCKS-Futures tick up ahead of jobless claims data Reuters
07:00AM  Must-See Charts: 5 Big Stocks to Trade for Gains at TheStreet
13-Aug-14 08:59PM  The F.D.A. Approves a Pill to Help People Stay Asleep at New York Times
08:59PM  The F.D.A. Approves a Pill to Help People Stay Asleep at New York Times
05:58PM  Merck Statement regarding Role of PNEUMOVAX┬« 23 (Pneumococcal Vaccine Polyvalent) in Updated ACIP Recommendations for Pneumococcal Vaccination in Adults Business Wire
04:49PM  FDA Approves BELSOMRA┬« (suvorexant) for the Treatment of Insomnia Business Wire
04:39PM  FDA approves new sleeping drug from Merck AP
04:30PM  Stocks close higher for the third time in four days on tech boost at CNBC
03:46PM  U.S. FDA approves Merck insomnia drug Reuters
03:41PM  Merck Wins U.S. Approval of New Type of Sleeping Pill at Bloomberg
02:29PM  Stocks higher on biotech, transports at CNBC
01:49PM  Stocks higher on biotech, transports; Nasdaq up 1% at CNBC
01:13PM  20 U.S. companies that paid 0% in taxes Yahoo Finance
12:46PM  Stocks higher on biotech, transports at CNBC
11:59AM  Stocks rise, all S&P sectors gain on easing geopolitics at CNBC
11:40AM  [video] Investors should expect more from Merck: Pro at CNBC
11:28AM  Stocks rise, all S&P sectors gain on easing geopolitics at CNBC
10:25AM  Stocks hold gains; business inventories up, geopolitics in backseat at CNBC
08:59AM  [$$] Germany's Merck Still Lacks Direction at The Wall Street Journal
01:57AM  [$$] Merck KGaA Net Profit Falls at The Wall Street Journal
01:16AM  Merck KGaA Profit Rises as AZ Acquisition Offsets Euro at Bloomberg
12:34AM  Europe set to open mixed; BoE report ahead at CNBC
12-Aug-14 10:48AM  Intercept Pharma Soars On Liver-Disease Drug Data at Investor's Business Daily
09:46AM  Unlocking the Mystery; Why US 10 Year Treasury Yields are Down at 2.4%, Ten Things You Need to Know at Forbes
09:28AM  [video] Cramer's Mad Dash: Intercept soars at CNBC
11-Aug-14 12:45PM  Merck KGaA is Fined by Brazil for Conspiring to Thwart Generic Drugs at The Wall Street Journal
08-Aug-14 01:03PM  Drugs Stocks On The Rise With Help From 3 Stocks at TheStreet
07-Aug-14 05:04PM  MERCK & CO. INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
06:51AM  [video] Clearing FDA hurdles at CNBC
06:45AM  SNB Trims Holdings in Apple, Exxon, J&J, SEC Filing Shows at Bloomberg
06-Aug-14 06:00AM  The R&D Hall of Fame: Who makes the cut? at CNBC
06:00AM  The R&D Hall of Fame: Which companies got elected? at CNBC
05-Aug-14 01:00PM  Merck Publishes 2013 Global Corporate Responsibility Report Business Wire
07:33AM  Saving kids: When unapproved drugs are the only hope at CNBC
06:00AM  Merck Completes Tender Offer to Acquire Idenix Business Wire
04-Aug-14 01:10PM  [video] Pros share top value plays at CNBC
31-Jul-14 03:30PM  3 Reasons To Buy Merck For The Long Term Benzinga
02:12PM  Len Schleifer's Science Focus Pays Off At Regeneron at Investor's Business Daily
30-Jul-14 07:01PM  Merck, J&J, Baxter Provide Healthy Dividend Stream at Investor's Business Daily
04:07PM  Stocks mixed; Fed tapers and GDP better than forecast at CNBC
03:48PM  US stocks mixed after Fed retains dovish stance at CNBC
03:07PM  Second Quarter Results Show Earnings And Revenue Growth at Forbes
02:56PM  US stocks mixed after Fed retains dovish stance at CNBC
02:36PM  Stocks mostly higher as Fed retains dovish stance at CNBC
02:07PM  S&P 500 turns positive as stocks cut losses after FOMC at CNBC
11:53AM  Stocks mostly drop; upbeat GDP fuels rate-hike talk at CNBC
10:26AM  Hospira Beats on Earnings and Sales in Q2, Boosts Guidance Zacks
09:23AM  Pharma ETFs in Focus on String of Earnings Beat Zacks
29-Jul-14 07:15PM  Stocks close lower as global tensions take a toll at USA TODAY
05:46PM  Stocks close lower as global tensions take a toll at USA TODAY
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. The company's Pharmaceutical segment offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, immunology, infectious diseases, and others. This segment also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. Its Animal Health segment discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. The company's Consumer Care segment develops, manufactures, and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant sprays; and products for occasional constipation, frequent heartburn, and overactive bladder in women; foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has collaborations with AstraZeneca LP, Pfizer Inc., Samsung Bioepis Co., Ltd., Sanofi Pasteur S.A., and Sysmex Inostics GmbH. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FRAZIER KENNETH CChairman, President & CEOAug 11Option Exercise34.2012,875440,272345,562Aug 12 09:01 AM
FRAZIER KENNETH CChairman, President & CEOAug 11Sale57.0010,058573,306335,504Aug 12 09:01 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Option Exercise45.3823,4001,061,82042,844Aug 05 09:56 AM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerAug 04Sale56.6428,6691,623,72014,175Aug 05 09:56 AM
REPRESAS CARLOS EDirectorAug 01Option Exercise35.195,000175,9505,500Aug 05 10:16 AM
FRAZIER KENNETH CChairman, President & CEOJul 10Option Exercise34.2012,876440,307351,474Jul 10 03:47 PM
FRAZIER KENNETH CChairman, President & CEOJul 10Sale58.039,987579,545341,487Jul 10 03:47 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Option Exercise30.01180,0475,403,278273,611Jul 08 02:16 PM
GRADDICK WEIR MIRIAN MExe V-P, HRJul 07Sale59.16180,04710,650,93293,564Jul 08 02:16 PM
Deese Willie AExe V-P & Pres. MMDJun 27Option Exercise27.8572,2902,013,164178,512Jun 30 04:23 PM
Deese Willie AExe V-P & Pres. MMDJun 27Sale58.2672,2904,211,254106,222Jun 30 04:23 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 14Sale55.9110,527588,5840May 14 02:48 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Option Exercise34.2012,876440,307345,927May 13 03:56 PM
FRAZIER KENNETH CChairman, President & CEOMay 09Sale55.0010,220562,100335,707May 13 03:56 PM
Schechter Adam HEVP & Pres-Global Human HealthMay 04Option Exercise0.0019,147019,147May 06 04:03 PM
Golestani ClarkEVP & Chief Info OfficerMay 04Option Exercise0.002,05109,278May 06 04:02 PM
GRADDICK WEIR MIRIAN MExe V-P, HRMay 04Option Exercise0.009,300098,387May 06 04:02 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareMay 04Option Exercise0.005,470038,311May 06 04:02 PM
Karachun Rita ASr. VP Fince-Global ControllerMay 04Option Exercise0.004,240011,999May 06 04:02 PM
Kuhlik Bruce NExe V-P & Gen CounselMay 04Option Exercise0.009,8470132,660May 06 04:02 PM
Rosenblatt MichaelExec V-P & Chief Med OfficerMay 04Option Exercise0.004,103026,720May 06 04:02 PM
AMBROSE ADELE DSr.V-P & Chief Comuns OfficerMay 04Option Exercise0.004,103020,828May 06 04:01 PM
Deese Willie AExe V-P & Pres. MMDMay 04Option Exercise0.007,6590109,671May 06 04:01 PM
FRAZIER KENNETH CChairman, President & CEOMay 04Option Exercise0.0041,0280351,522May 06 04:01 PM
HARRISON WILLIAM B JRDirectorApr 25Option Exercise47.235,000236,1506,400Apr 29 11:36 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Option Exercise34.2012,876440,307320,541Apr 11 09:53 AM
FRAZIER KENNETH CChairman, President & CEOApr 10Sale57.2410,047575,108310,494Apr 11 09:53 AM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Option Exercise39.90145,2255,794,929267,070Apr 04 05:07 PM
Kuhlik Bruce NExe V-P & Gen CounselApr 04Sale56.43145,2258,195,164121,845Apr 04 05:07 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Option Exercise48.246,375307,53012,036Feb 14 05:11 PM
Golestani ClarkEVP & Chief Info OfficerFeb 14Sale55.475,990332,2766,046Feb 14 05:11 PM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Option Exercise36.5649,7501,818,86071,457Feb 14 11:17 AM
Heller Bridgette PExe.VP & Pres.Con.Hlth.CareFeb 13Sale55.0443,8702,414,57027,587Feb 14 11:17 AM
FRAZIER KENNETH CChairman, President & CEOFeb 11Option Exercise48.2445,0002,170,800304,349Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Option Exercise48.2410,000482,40020,697Feb 11 05:07 PM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Option Exercise47.6518,000857,70518,000Feb 13 10:12 AM
Schechter Adam HEVP & Pres-Global Human HealthFeb 11Sale55.6118,0001,000,9350Feb 13 10:12 AM
FRAZIER KENNETH CChairman, President & CEOFeb 11Sale54.5241,5202,263,683262,829Feb 11 05:34 PM
Canan JohnSr.V-P Finc-Global ControllerFeb 11Sale55.7010,000557,00210,697Feb 11 05:07 PM
WENDELL PETER CDirectorFeb 10Option Exercise47.235,000236,1506,000Feb 11 03:48 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Option Exercise48.2420,000964,800156,049Feb 11 03:54 PM
WEEKS WENDELL PDirectorFeb 10Option Exercise47.235,000236,1505,100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDFeb 10Sale54.6850,0002,734,155106,049Feb 11 03:54 PM
WENDELL PETER CDirectorFeb 10Sale54.445,000272,1931,000Feb 11 03:48 PM
WEEKS WENDELL PDirectorFeb 10Sale54.265,000271,283100Feb 11 03:41 PM
Deese Willie AExe V-P & Pres. MMDJan 27Option Exercise47.7930,0001,433,700136,049Jan 28 10:09 AM